Evidence map›Paper›PMID 39603773›Full record

ArticleClinical lymphoma, myeloma & leukemia2024

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin H Nassar, Elio Adib, Noha Abdel-Wahab, Nikita Chintapally, Claire E Drolen, Tatyana Feldman, Tarek Haykal and 20 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical lymphoma, myeloma & leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Kathryn LurainHIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: kathryn.lurain@nih.gov.
Talal El ZarifYale University School of Medicine, New Haven, CT.
Ramya RamaswamiHIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Amin H NassarYale University School of Medicine, New Haven, CT.
Elio AdibBrigham and Women's Hospital, Department of Radiation Oncology, Boston, MA.
Noha Abdel-WahabMD Anderson Cancer Center, Houston, TX.
Nikita ChintapallyMedstar/Georgetown-Washington Hospital Center, Washington, DC.
Claire E DrolenUniversity of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.
Tatyana FeldmanJohn Theurer Cancer Center, Hackensack, NJ.
Tarek HaykalDepartment of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC; Ohio State University Comprehensive Cancer Center, Columbus, OH.
Caroline A NebhanVanderbilt University Medical Center, Nashville, TN.
Swetha KambhampatiCity of Hope Medical Center, Duarte, CA.
Mingjia LiOhio State University Comprehensive Cancer Center, Columbus, OH.
Arjun MittraOhio State University Comprehensive Cancer Center, Columbus, OH.
Michael LorentsenUniversity of North Carolina, Chapel Hill, NC.
Chul KimMedstar Georgetown University Hospital, Washington, DC.
Alexandra DrakakiUniversity of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.
Michael MorseDepartment of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC.
Douglas B JohnsonVanderbilt University Medical Center, Nashville, TN.
Ankit ManglaUniversity Hospital Seidman Cancer Center, Cleveland, OH.
Christopher DittusUniversity of North Carolina, Chapel Hill, NC.
Praful RaviDana-Farber Cancer Institute, Boston, MA.
Robert A BaiocchiOhio State University Comprehensive Cancer Center, Columbus, OH.
Elizabeth Y ChiaoMD Anderson Cancer Center, Houston, TX.
Paul G RubinsteinJohn Stroger Cook County Hospital, Chicago, IL.
Sarvari V YellapragadaDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine & Michael E. DeBakey VA Medical Center, Houston, TX.
Ann S LaCasceDana-Farber Cancer Institute, Boston, MA.
Guru P SonpavdeDana-Farber Cancer Institute, Boston, MA.
Abdul Rafeh NaqashStephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.
Alex F HerreraCity of Hope Medical Center, Duarte, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39603773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.